Karsten Voermann

Karsten Voermann serves as the Chief Financial Officer at GoodRx since February 2020, previously holding the same role at Mercer Advisors where leadership resulted in a successful sale process and significant EBITDA expansion. Voermann’s tenure at Ibotta was marked by a substantial scaling of 20x, while the role at Worldpay involved IPO preparation and a successful sale to Vantiv. Earlier career achievements include a focus on tech licensing at Pendrell Corporation, resulting in a 10x revenue increase, and various managerial positions at CPA.com and consulting roles at Bain & Company and McKinsey & Company. Voermann holds an MBA from Harvard Business School and an HBA from Ivey Business School at Western University.